Latest News

Features Headliner: Scientist CEO sets sights on Sierra Leone

Headliner: Scientist CEO sets sights on Sierra Leone

Thomas Sack, President and CEO, MRIGlobal

Features Meg Columbia-Walsh, Founder & CEO, Inverse Mobile

Meg Columbia-Walsh, Founder & CEO, Inverse Mobile

Session: Inter-generational CEO Summit Panel

Features Josh Stein, CEO & Co-Founder, AdhereTech

Josh Stein, CEO & Co-Founder, AdhereTech

Session: Inter-generational CEO Summit Panel

Features Benjamin Wolin, Chief Executive Officer & Co-Founder

Benjamin Wolin, Chief Executive Officer & Co-Founder

Session: Inter-generational CEO Summit Panel

Features Ingo Elfering, Indivior, Chief Information Officer

Ingo Elfering, Indivior, Chief Information Officer

Session: Navigating Pharma Internal

Features Michele Polz, Biogen Idec, Head, Patient Insights, Global Commercial Strategy

Michele Polz, Biogen Idec, Head, Patient Insights, Global Commercial Strategy

Session: Rapid innovation and Big Pharma

Payer/Managed Markets Five things for pharma marketers to know: Friday, January 23

Five things for pharma marketers to know: Friday, January 23

Express Scripts takes aim at high-priced cancer drugs; FDA panel recommends approval for Astellas orphan drug; GSK Ebola Vaccine could touch down in Liberia as early as next week.

Pharmaceutical

Actavis CEO touts his acquisition strategy

Brent Saunders, the mind behind the $66 billion acquisition of Allergan, which elevated Actavis to the tenth-largest drugmaker in the world, tells Forbes that growth through acquisition is not simply a short-term tactic but part of a long-term strategy.

Pharmaceutical

Rx painkillers increase risk of birth defects: CDC

The CDC and March of Dimes Foundation are asking prescribers to discuss safer alternatives than opioid painkillers for women who may become pregnant.

Biotech MM&M's 5 minutes with: Mark Rothera, chief commercial officer, PTC Therapeutics

MM&M's 5 minutes with: Mark Rothera, chief commercial officer, PTC Therapeutics

The biotech exec speaks about the global launch of his firm's lead product, Duchenne drug Translarna.


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.